BioVie Inc (BIVI)
3.16
+0.05
(+1.61%)
USD |
NASDAQ |
Nov 22, 15:03
BioVie Total Liabilities (Quarterly): 7.171M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 7.171M |
June 30, 2024 | 9.702M |
March 31, 2024 | 12.85M |
December 31, 2023 | 14.00M |
September 30, 2023 | 16.21M |
June 30, 2023 | 19.76M |
March 31, 2023 | 23.46M |
December 31, 2022 | 21.12M |
September 30, 2022 | 16.90M |
June 30, 2022 | 16.44M |
March 31, 2022 | 16.23M |
December 31, 2021 | 15.81M |
September 30, 2021 | 1.744M |
June 30, 2021 | 0.9964M |
March 31, 2021 | 1.491M |
December 31, 2020 | 0.3849M |
September 30, 2020 | 0.2657M |
June 30, 2020 | 23.58M |
March 31, 2020 | 4.654M |
December 31, 2019 | 4.384M |
September 30, 2019 | 11.33M |
June 30, 2019 | 0.4435M |
March 31, 2019 | 0.1791M |
Date | Value |
---|---|
December 31, 2018 | 0.1048M |
September 30, 2018 | 0.1831M |
June 30, 2018 | 2.064M |
March 31, 2018 | 1.660M |
December 31, 2017 | 1.455M |
September 30, 2017 | 1.241M |
June 30, 2017 | 1.207M |
March 31, 2017 | 0.9785M |
December 31, 2016 | 1.151M |
September 30, 2016 | 0.9614M |
June 30, 2016 | 0.8032M |
March 31, 2016 | 0.4447M |
December 31, 2015 | 0.4043M |
September 30, 2015 | 0.3728M |
June 30, 2015 | 0.3236M |
March 31, 2015 | 0.2832M |
December 31, 2014 | 0.2472M |
September 30, 2014 | 0.2036M |
June 30, 2014 | 0.1615M |
March 31, 2014 | 0.0025M |
December 31, 2013 | 0.0168M |
September 30, 2013 | 0.0086M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.2657M
Minimum
Sep 2020
23.58M
Maximum
Jun 2020
11.36M
Average
13.42M
Median
Total Liabilities (Quarterly) Benchmarks
Catalyst Pharmaceuticals Inc | 111.07M |
MediciNova Inc | 2.999M |
NovaBay Pharmaceuticals Inc | 2.805M |
Palatin Technologies Inc | 11.10M |
iBio Inc | 6.763M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 21.24M |
Shareholders Equity (Quarterly) | 14.07M |